The world's largest vaccine manufacturer wants to conduct trials of Novavax's COVID-19 vaccine in India. The Serum Institute of India has applied for government approval, hours after the US drugmaker announced its vaccine was nearly 90 per cent effective in a UK trial.
Subscribe to our channel here: [ Ссылка ]
Subscribe to our news service on Telegram: [ Ссылка ]
Follow us:
CNA: [ Ссылка ]
CNA Lifestyle: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
